Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A rural China hypertension program keeps delivering results long after it wrapped up. Seven-year data from the CRHCP trial show that a community-based, nonphysician-led blood pressure intervention sustained lower BP, reduced cardiovascular events, and cut dementia risk by 15% — even 4 years after the active program ended. Experts say the model has global implications for scalable hypertension management.
A community-based hypertension program in rural China is still paying dividends years after it closed shop. New 7-year data from the China Rural Hypertension Control Project (CRHCP), presented at ESC Congress 2026, show that a nonphysician-led intensive blood pressure intervention delivered lasting reductions in cardiovascular events and dementia risk — well beyond the program's 4-year active phase.
The cluster-randomized trial enrolled nearly 34,000 adults across 326 villages. Trained community health workers initiated and titrated antihypertensive medications under physician supervision, while also coaching patients on lifestyle changes and home BP monitoring. Even after all study support was withdrawn, the intervention group maintained meaningfully lower blood pressure and better outcomes than those receiving usual care.
Why it matters: Hypertension is the single biggest modifiable risk factor for both cardiovascular disease and dementia. This study shows that scalable, community-based programs — even in resource-limited rural settings — can produce durable benefits. With 152.8 million people projected to have dementia by 2050, experts say the CRHCP model offers a practical blueprint for global hypertension control.
